Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling
Tóm tắt
Từ khóa
Tài liệu tham khảo
1) Palo M, Hollander J, Suominen J, Yliruusi J, Sandler N. 3D printed drug delivery devices: perspectives and technical challenges. <i>Expert Rev. Med. Devices</i>, <b>14</b>, 685–696 (2017).
2) Alam MS, Akhtar A, Ahsan I, Shafiq-Un-Nabi S. Pharmaceutical product development exploiting 3D printing technology: conventional to novel drug delivery system. <i>Curr. Pharm. Des.</i>, <b>24</b>, 5029–5038 (2018).
3) Preis M, Oblom H. 3D-printed drugs for children—are we ready yet? <i>AAPS PharmSciTech</i>, <b>18</b>, 303–308 (2017).
4) Khaled SA, Alexander MR, Wildman RD, Wallace MJ, Sharpe S, Yoo J, Roberts CJ. 3D extrusion printing of high drug loading immediate release paracetamol tablets. <i>Int. J. Pharm.</i>, <b>538</b>, 223–230 (2018).
5) Afsana JV, Jain V, Haider N, Jain K. 3D printing in personalized drug delivery. <i>Curr. Pharm. Des.</i>, <b>24</b>, 5062–5071 (2018).
6) Arafat B, Qinna N, Cieszynska M, Forbes RT, Alhnan MA. Tailored on demand anti-coagulant dosing: an <i>in vitro</i> and <i>in vivo</i> evaluation of 3D printed purpose-designed oral dosage forms. <i>Eur. J. Pharm. Biopharm.</i>, <b>128</b>, 282–289 (2018).
7) Pietrzak K, Isreb A, Alhnan MA. A flexible-dose dispenser for immediate and extended release 3D printed tablets. <i>Eur. J. Pharm. Biopharm.</i>, <b>96</b>, 380–387 (2015).
8) Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. Patient acceptability of 3D printed medicines. <i>Int. J. Pharm.</i>, <b>530</b>, 71–78 (2017).
9) Korte C, Quodbach J. 3D-printed network structures as controlled-release drug delivery systems: dose adjustment, API release analysis and prediction. <i>AAPS PharmSciTech</i>, <b>19</b>, 3333–3342 (2018).
10) Tagami T, Fukushige K, Ogawa E, Hayashi N, Ozeki T. 3D printing factors important for the fabrication of polyvinylalcohol filament-based tablets. <i>Biol. Pharm. Bull.</i>, <b>40</b>, 357–364 (2017).
11) Chai X, Chai H, Wang X, Yang J, Li J, Zhao Y, Cai W, Tao T, Xiang X. Fused deposition modeling (FDM) 3D printed tablets for intragastric floating delivery of domperidone. <i>Sci. Rep.</i>, <b>7</b>, 2829 (2017).
12) Pereira BC, Isreb A, Forbes RT, Dores F, Habashy R, Petit JB, Alhnan MA, Oga EF. ‘Temporary plasticiser’: a novel solution to fabricate 3D printed patient-centred cardiovascular ‘polypill’ architectures. <i>Eur. J. Pharm. Biopharm.</i>, <b>135</b>, 94–103 (2019).
13) Kollamaram G, Croker DM, Walker GM, Goyanes A, Basit AW, Gaisford S. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. <i>Int. J. Pharm.</i>, <b>545</b>, 144–152 (2018).
14) Long J, Gholizadeh H, Lu J, Bunt C, Seyfoddin A. Application of fused deposition modelling (FDM) method of 3D printing in drug delivery. <i>Curr. Pharm. Des.</i>, <b>23</b>, 433–439 (2017).
15) Censi R, Gigliobianco MR, Casadidio C, Di Martino P. Hot melt extrusion: highlighting physicochemical factors to be investigated while designing and optimizing a hot melt extrusion process. <i>Pharmaceutics</i>, <b>10</b>, 89 (2018).
16) Tan DK, Maniruzzaman M, Nokhodchi A. Advanced pharmaceutical applications of hot-melt extrusion coupled with fused deposition modelling (FDM) 3D printing for personalised drug delivery. <i>Pharmaceutics</i>, <b>10</b>, 203 (2018).
17) Tagami T, Nagata N, Hayashi N, Ogawa E, Fukushige K, Sakai N, Ozeki T. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler. <i>Int. J. Pharm.</i>, <b>543</b>, 361–367 (2018).
18) Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. <i>Eur. J. Pharm. Sci.</i>, <b>13</b>, 123–133 (2001).
19) Singhvi G, Songh M. Review: <i>In vitro</i> drug release characterization models. <i>Int. J. Pharm. Sci. Res.</i>, <b>2</b>, 77–84 (2011).
20) Kunnumakkara AB, Bordoloi D, Harsha C, Banik K, Gupta SC, Aggarwal BB. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways. <i>Clin. Sci.</i> (Lond.), <b>131</b>, 1781–1799 (2017).
21) Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. <i>Anticancer Res.</i>, <b>35</b>, 645–651 (2015).
22) Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. <i>Acta Pol. Pharm.</i>, <b>67</b>, 217–223 (2010).